◀ Back to MAPK3
MAPK3 — PPP5C
Protein-Protein interactions - manually collected from original source literature:
Studies that report less than 10 interactions are marked with *
Text-mined interactions from Literome
Suzuki et al., Surgery 2006
(Disease Models, Animal...) :
PPT or E2 also
prevented T-H mediated activation of
MAPK in KC
Chen et al., Free Radic Biol Med 2008
:
Overexpression of PP2A or
PP5 partially
prevented Cd-induced activation of
Erk1/2 and JNK, as well as cell death
Cignarella et al., J Pharmacol Exp Ther 2009
(Diabetes Mellitus, Experimental...) :
However,
extracellular signal regulated kinase 1/2 signaling was
activated by DPN but not by
PPT in cytokine treated SMCs
Hershberger et al., J Steroid Biochem Mol Biol 2009
(Carcinoma, Non-Small-Cell Lung...) :
PPT and DPN
increased MAPK phosphorylation ( 2.5-fold and 3.7-fold, respectively )
Sanchez-Ortiz et al., J Neurochem 2009
(Alzheimer Disease...) :
In contrast, over-expression of
PP5 , but not the inactive mutant, PP5 ( H304Q ),
prevented MAPK phosphorylation and neurotoxicity induced by Abeta
Han et al., Carcinogenesis 2012
:
Overexpression of PP2A or
PP5 partially
prevented curcumin induced activation of JNK and
Erk1/2 phosphorylation as well as cell death